Antiemetic Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Antiemetic Drugs Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Antiemetic Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Dopamine Antagonist
- 1.3.3 5-HT-3 Receptor Antagonist
- 1.3.4 NK1 Receptor Antagonist
- 1.3.5 Cannabinoid Receptor Antagonist
1.4 Market Segment by Application
- 1.4.1 Global Antiemetic Drugs Market Share by Application (2019-2025)
- 1.4.2 Chemotherapy
- 1.4.3 Gastroenteritis
- 1.4.4 Surgery
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Antiemetic Drugs Market Size
- 2.1.1 Global Antiemetic Drugs Revenue 2014-2025
- 2.1.2 Global Antiemetic Drugs Sales 2014-2025
2.2 Antiemetic Drugs Growth Rate by Regions
- 2.2.1 Global Antiemetic Drugs Sales by Regions 2014-2019
- 2.2.2 Global Antiemetic Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Antiemetic Drugs Sales by Manufacturers
- 3.1.1 Antiemetic Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Antiemetic Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Antiemetic Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Antiemetic Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antiemetic Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Antiemetic Drugs Price by Manufacturers
3.4 Key Manufacturers Antiemetic Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antiemetic Drugs Market
3.6 Key Manufacturers Antiemetic Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Dopamine Antagonist Sales and Revenue (2014-2019)
- 4.1.2 5-HT-3 Receptor Antagonist Sales and Revenue (2014-2019)
- 4.1.3 NK1 Receptor Antagonist Sales and Revenue (2014-2019)
- 4.1.4 Cannabinoid Receptor Antagonist Sales and Revenue (2014-2019)
4.2 Global Antiemetic Drugs Sales Market Share by Type
4.3 Global Antiemetic Drugs Revenue Market Share by Type
4.4 Antiemetic Drugs Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Antiemetic Drugs Sales by Application

6 United States

6.1 United States Antiemetic Drugs Breakdown Data by Company
6.2 United States Antiemetic Drugs Breakdown Data by Type
6.3 United States Antiemetic Drugs Breakdown Data by Application

7 European Union

7.1 European Union Antiemetic Drugs Breakdown Data by Company
7.2 European Union Antiemetic Drugs Breakdown Data by Type
7.3 European Union Antiemetic Drugs Breakdown Data by Application

8 China

8.1 China Antiemetic Drugs Breakdown Data by Company
8.2 China Antiemetic Drugs Breakdown Data by Type
8.3 China Antiemetic Drugs Breakdown Data by Application

9 Rest of World

9.1 Rest of World Antiemetic Drugs Breakdown Data by Company
9.2 Rest of World Antiemetic Drugs Breakdown Data by Type
9.3 Rest of World Antiemetic Drugs Breakdown Data by Application
9.4 Rest of World Antiemetic Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Antiemetic Drugs Sales by Countries
- 9.4.2 Rest of World Antiemetic Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Antiemetic Drugs Sales Channels
- 11.2.2 Antiemetic Drugs Distributors
11.3 Antiemetic Drugs Customers

12 Market Forecast

12.1 Global Antiemetic Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Antiemetic Drugs Sales Forecast by Type
12.3 Global Antiemetic Drugs Sales Forecast by Application
12.4 Antiemetic Drugs Forecast by Regions
- 12.4.1 Global Antiemetic Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antiemetic Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
In 2019, the market size of Antiemetic Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antiemetic Drugs.

This report studies the global market size of Antiemetic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antiemetic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical

Market Segment by Product Type
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist

Market Segment by Application
Chemotherapy
Gastroenteritis
Surgery

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antiemetic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antiemetic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antiemetic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025